Posted: May 20, 2016
The New York Times reports that the Food and Drug Administration has delayed until 2017 a decision on whether or not to require the manufacturers of generic medications to warn patients of the potentially dangerous side-effects of their drugs. The argument made by the manufacturers of generic...
